Drug safety in pregnancy
著者
書誌事項
Drug safety in pregnancy
Elsevier , Sole distributor for the USA and Canada, Elsevier Science Pub. Co., 1990
大学図書館所蔵 全11件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references
Includes index
内容説明・目次
内容説明
This book combines the perspectives of clinical and laboratory medicine so as to present critically considered and practical information to the clinician concerning drug-induced injury to the human embryo and fetus. The information that has been included has been thoroughly and independently evaluated by the authors at source. Animal and pharmacokinetic data have been used when their relevance to the human situation is direct, or where they demonstrate important principles. Classical teratology syndromes, such as those caused by thalidomide or diethystilboestrol have been examined in some detail, even though the use of these agents in pregnancy no longer reflects contemporary practice. This has been done because they add an understanding of clinical teratology. "Drug Safety in Pregnancy" can be regarded as a companion book to Meyler's Side Effects of Drugs, and to the Side Effects of Drugs Annuals, and care has been taken to include material contained in recent editions of those volumes. The book provides a comprehensive and critical data base for any clinician, pharmacologist or research worker concerned with the safe use of medicines in the pregnant woman.
目次
Preface. Fontispiece. How to use this book. 1. Thalidomide. 2. Amphetamines. 3. Tricyclic antidepressants. 4. Lithium. 5. Ethanol. 6. Cigarette smoking. 7. Caffeine. 8. Drugs of abuse. 9. Neuroleptic agents. 10. Benzodiazepines. 11. Anticonvulsants. 12. Opioid analgesics. 13. Nonsteroidal anti-inflammatory agents, and paracetamol. 14. Anaesthetic agents (general and local anaesthetics). 15. Sympathomimetic agents. 16. Antihypertensive drugs, and beta adrenoreceptor blocking agents. 17. Diuretics. 18. Penicillamine and gold. 19. Antibiotics and chemotherapeutic agents. 20. Drugs used in tuberculosis. 21. Antimalarials. 22. Vaccines. 23. Anticoagulants. 24. Haematinics. 25. Drugs acting on the gastrointestinal tract. 26. Anti-emetic agents. 27. Vitamins and the retinoids. 28. Corticosteroids. 29. Hormonal contraceptives. 30. Diethylstilboestrol, and related agents affecting fetal sex hormone development. 31. Spermicidal agents. 32. Thyroid and antithyroid drugs. 33. Oral hypoglycaemic agents. 34. Prostaglandins. 35. Cytotoxic and immunosuppresive agents. Appendices: I. Abnormal fetal genitourinary system development associated with drugs. II. Drugs associated with polydactyly and syndactyly. III. Reported association of congenital abnormalities of bones and intra-uterine drug exposure. IV. Limb reduction deformities associated with drug exposure in utero. V. Drug related anencephaly, exencephaly and spina bifida in humans. VI. Human congenital cardiac defects that have been associated with drug exposure in utero. VII. Drugs associated with congenital hearing loss and/or microtia. VIII. Drugs associated with congenital ocular defects. IX. Drugs associated with oral clefts. X. X-irradiation. XI. Behavioural teratology. XII. The kinetics of drugs during pregnancy - general principles. XIII. Evolution and prediction of drug safety in pregnancy. XIV. Attempted suicide with drugs in pregnancy. Index of drugs. Index of side effects.
「Nielsen BookData」 より